Clover Health Investments, Corp.
- Stock
- Ticker CLOV
- ISIN US18914F1030
- Nasdaq
Performance, volatility and drawdowns of Clover Health Investments, Corp. since 06/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $4,973. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −97.2% in 04/2024, measured from the peak in 06/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 337 | 462 | 478 | 497 | 488 | 749 | 743 | 759 |
| Operating income | -21 | -1.3 | -11 | -24 | -49 | 27 | 28 | 6.4 |
| EBITDA | -21 | -0.8 | -10 | -24 | -49 | 28 | 29 | 7.0 |
| Net income | -22 | -1.3 | -11 | -24 | -49 | 27 | 28 | 6.4 |
| Earnings per share | – | 0.00 | -0.02 | -0.05 | – | 0.05 | 0.05 | 0.01 |
| Balance sheet | ||||||||
| Total assets | 581 | 584 | 575 | 560 | 541 | 698 | 720 | 754 |
| Liabilities | 240 | 248 | 231 | 219 | 232 | 358 | 344 | 363 |
| Equity | 341 | 336 | 344 | 341 | 309 | 339 | 376 | 391 |
| Cash | 195 | 155 | 189 | 190 | 78 | 173 | 199 | 268 |
| Cash flow | ||||||||
| Operating cash flow | -86 | -16 | 5.4 | 12 | -68 | 108 | 25 | 70 |
| Capital expenditure | -0.3 | -0.2 | -0.6 | -0.7 | -0.6 | -0.9 | -0.7 | -0.9 |
| Free cash flow | -86 | -16 | 4.8 | 11 | -69 | 107 | 25 | 69 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2024 at +230.8%, weakest 2021 at −77.8%. 2 of 5 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 6 Nov 2026 | $0.01 |
| 7 Aug 2026 | $0.05 |
| 8 May 2026 | $0.05 |
| 27 Feb 2026 | – |
| 7 Nov 2025 | −$0.05 |
| 8 Aug 2025 | −$0.02 |
| 9 May 2025 | $0.00 |
| 3 Mar 2025 | – |
| 8 Nov 2024 | – |
| 8 Aug 2024 | – |
| 7 May 2024 | – |
| 14 Mar 2024 | −$0.14 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.9bn
- Market cap in trading currency
- $2.08bn
- Enterprise value
- $1.75bn
- P/E
- –
- P/S
- 0.76
- P/B
- 5.32
- EV/Sales
- 0.64
- EV/EBITDA
- 120.4
- Earnings yield
- –
- FCF yield
- 6.4%
Results (last four quarters)
- Revenue
- $2.74bn
- Gross profit
- –
- EBITDA
- $14.6m
- Net income
- $12.5m
- Earnings per share
- –
- Revenue per share
- $4.91
- Revenue growth
- +52.9%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- 0.5%
- Net margin
- 0.5%
- Return on equity
- 3.4%
- Return on assets
- 1.7%
Balance sheet and cash flow
- Cash
- $327m
- Cash per share
- $0.59
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 1.55
- Book value per share
- $0.70
- Operating cash flow
- $135m
- Free cash flow
- $132m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 557m
- Volume
- 7.23m
- Avg. volume 3 months
- 4.27m
- Relative volume
- 1.6
Price and technicals
- Price
- $3.73
- 1 day
- −1.1%
- 52-week high
- $5.41
- 52-week low
- $1.70
- Distance to 52-week high
- −31.1%
- Distance to 52-week low
- +119.4%
- Distance to 50-day line
- −18.7%
- Distance to 200-day line
- +0.7%
- RSI (14)
- 31
- Volatility 1M
- 77.9%
Performance
- 1 week
- −24.8%
- 1 month
- −21.1%
- 3 months
- −9.2%
- 6 months
- +5.1%
- YTD
- +58.7%
- 1 year
- +60.8%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has CLOV performed since 06/2020?
$10,000 grew to $3,657 by 20 Nov 2026, which is −14.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is CLOV?
Volatility was 91.0% per year, measured on monthly returns. The largest decline from a peak was −97.2%, with the low in 04/2024.
How does CLOV compare with a broad equity ETF?
Over the same period Global equities (VT) returned +12.8% per year at 15.1% volatility, CLOV returned −14.5% at 91.0%. The correlation of monthly returns was 0.37; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.